Sarcoidosis 1

Common Name(s)

Sarcoidosis 1

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Sarcoidosis 1" for support, advocacy or research.

Logo
Foundation for Sarcoidosis Research

The Foundation for Sarcoidosis Research is the nation's leading nonprofit organization dedicated to finding a cure for this disease and to improving care for sarcoidosis patients. Since its establishment in 2000, FSR has funded numerous domestic and international research efforts and worked diligently to provide resources to thousands.

Last Updated: 19 Feb 2013

View Details
Logo
Sarcoidosis Australia

Bring fellow sufferers together to support each other and their families Provide and share information and experiences, acting as a forum to help those affected to understand the condition Support the medical profession in the early diagnosis and treatment of those with these diseases Support the medical profession in research into the disease Heighten awareness of the disease in Australia

Last Updated: 2 Mar 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Sarcoidosis 1" for support, advocacy or research.

Logo
Foundation for Sarcoidosis Research

The Foundation for Sarcoidosis Research is the nation's leading nonprofit organization dedicated to finding a cure for this disease and to improving care for sarcoidosis patients. Since its establishment in 2000, FSR has funded numerous domestic and international research efforts and worked diligently to provide resources to thousands.

http://www.stopsarcoidosis.org

Last Updated: 19 Feb 2013

View Details
Logo
Sarcoidosis Australia

Bring fellow sufferers together to support each other and their families Provide and share information and experiences, acting as a forum to help those affected to understand the condition Support the medical profession in the early diagnosis and treatment of those with these diseases Support the medical profession in research into the disease Heighten awareness of the disease in Australia

http://www.sarcoidosisaustralia.com

Last Updated: 2 Mar 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Sarcoidosis 1" returned 45 free, full-text research articles on human participants. First 3 results:

Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4 T Cell Proliferation.
 

Author(s): Lindsay J Celada, Joseph E Rotsinger, Anjuli Young, Guzel Shaginurova, Debresha Shelton, Charlene Hawkins, Wonder P Drake

Journal: Am. J. Respir. Cell Mol. Biol.. 2017 01;56(1):74-82.

 

Patients with progressive sarcoidosis exhibit increased expression of programmed death-1 (PD-1) receptor on their CD4 T cells. Up-regulation of this marker of T cell exhaustion is associated with a reduction in the proliferative response to T cell receptor (TCR) stimulation, a defect ...

Last Updated: 31 Dec 1969

Go To URL
Sarcoidosis and T-Helper Cells. Th1, Th17, or Th17.1?
 

Author(s): Steve N Georas, Timothy J Chapman, Elliott D Crouser

Journal: Am. J. Respir. Crit. Care Med.. 2016 06;193(11):1198-200.

 

Last Updated: 31 Dec 1969

Go To URL
Coexistence of early onset sarcoidosis and partial interferon-γ receptor 1 deficiency.
 

Author(s): Mustafa Çakan, Gonca Keskindemirci, Çiğdem Aydoğmuş, Hilal Akı, Nevin Hatipoğlu, Aysel Kıyak, Gönül Aydoğan, Nuray Aktay-Ayaz

Journal: Turk. J. Pediatr.. 2016 ;58(5):545-549.

 

Pediatric sarcoidosis comprises a spectrum of childhood granulomatous inflammatory conditions. Pathological hallmark of the disease is granuloma formation that is seen in the affected tissues and almost any organ or system can be involved. There are two forms of pediatric sarcoidosis. ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Sarcoidosis 1" returned 3 free, full-text review articles on human participants. First 3 results:

The Roles of T Helper 1, T Helper 17 and Regulatory T Cells in the Pathogenesis of Sarcoidosis.
 

Author(s): Esmaeil Mortaz, Fatemeh Rezayat, Davar Amani, Arda Kiani, Johan Garssen, Ian M Adcock, Aliakbar Velayati

Journal: Iran J Allergy Asthma Immunol. 2016 Aug;15(4):334-339.

 

Sarcoidosis is a systemic granulomatous disorder of unidentified etiology, with a heterogeneous clinical presentation. It is characterized by a reduced delayed-type hypersensitivity to tuberculin and common antigens. The balance between Th1, Th17 and Regulatory T(Treg) cells controls ...

Last Updated: 31 Dec 1969

Go To URL
Atypical Presentation of Sarcoidosis on ¹⁸F-FDG PET/CT.
 

Author(s): Prashant Jolepalem, Katie Zanyk McLean, Ching-Yee Oliver Wong

Journal: J Nucl Med Technol. 2014 Jun;42(2):114-5.

 

On (18)F-FDG PET, inflammatory processes can be one of the most confounding factors for interpretation, particularly when the presentation of the process is atypical, as it was in the case of sarcoidosis reported here. Clinicians should be aware that sarcoidosis may mimic lung malignancies ...

Last Updated: 31 Dec 1969

Go To URL
Primary care paradigm for management of sarcoidosis, Part 1.
 

Author(s): R C Young, R E Rachal, B Nelson-Knuckles, C N Arthur, H V Nevels

Journal: J Natl Med Assoc. 1997 Mar;89(3):181-90.

 

Sarcoidosis is a systemic granulomatous disease of undetermined etiology in which the immune system is overstimulated. Management of the patient with sarcoidosis entails continuity of patient care far beyond disease, even into remission. Care is comprehensive, including all involved ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 1 Aug 2016

Go to URL
Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome
 

Status: Recruiting

Condition Summary: Myelodysplastic Syndromes

 

Last Updated: 18 Dec 2017

Go to URL

Last Updated: 25 Jun 2018

Go to URL